C3.AI/$AI
1D1W1MYTD1Y5YMAX
About C3.AI
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions, namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications; C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications; and C3 Generative AI, which combines the utility of large language models. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.
- Ticker
- $AI
- Sector
- Software & Cloud Services
- Primary listing
- NYSE
- Employees
- 764
- Headquarters
- Redwood City, United States
- Website
- www.c3.ai
C3.AI Metrics
BasicAdvanced
$1.6B
-
-$3.35
2.03
-
Price and volume
Market cap
$1.6B
Beta
2.03
52-week high
$20.22
52-week low
$7.68
Average daily volume
4.8M
Financial strength
Current ratio
6.643
Quick ratio
6.343
Long term debt to equity
8.123
Total debt to equity
8.32
Profitability
EBITDA (TTM)
-474.116
Gross margin (TTM)
31.43%
Net profit margin (TTM)
-187.95%
Operating margin (TTM)
-194.86%
Effective tax rate (TTM)
-0.17%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
-33.09%
Return on equity (TTM)
-63.05%
Valuation
Price to revenue (TTM)
5.912
Price to book
2.36
Price to tangible book (TTM)
2.36
Price to free cash flow (TTM)
-7.701
Free cash flow yield (TTM)
-12.99%
Free cash flow per share (TTM)
-1.367
Growth
Revenue change (TTM)
-35.67%
Earnings per share change (TTM)
49.68%
3-year revenue growth (CAGR)
-2.11%
3-year earnings per share growth (CAGR)
11.01%
What the Analysts think about C3.AI
Analyst ratings (Buy, Hold, Sell) for C3.AI stock.
C3.AI Financial Performance
Revenues and expenses
C3.AI Earnings Performance
Company profitability
C3.AI News
AllArticlesVideos
AI's Need for Content Has Put Rare-Book Dealers in a Bind
WSJ1 week ago
Longevica Therapeutics Appoints Ex-Genentech Biotech Veteran Dr. Prasun Mishra as CEO to Advance World's Largest $13 Million Mammalian Longevity Study Toward Clinical Development
Business Wire2 weeks ago
C3 AI Announces New Employee Inducement Grant
Business Wire4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.